Market Summary
Affimed N.V. (AFMD): Are the Stars Lining Up for Investors?
Affimed NV (AFMD) unveiled how its immunological therapy has helped treat Hodgkin’s lymphoma. Even though the news only concerns four patients, it was well-received by
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.